• Study of the antihyperalgesic responses induced by the oral administration of PL265 in a model of bone cancer-induced pain in mice. Search of a possible synergistc potentiation by the administration of gabapentin or the CB2 selective agonist, AM1241 [FUO-EM-111-09]

    Organismo: PHARMALEADS

    Fecha de Inicio:
    18 de Marzo de 2009
    Fecha de Fin:
    17 de Marzo de 2010
    Investigador responsable:
    • Luis Menéndez Antolín
    • Ana Baamonde Arbaiza